Zydus Lifesciences Ltd (BOM:532321)
₹ 964.4 -8.55 (-0.88%) Market Cap: 970.41 Bil Enterprise Value: 965.67 Bil PE Ratio: 22.61 PB Ratio: 4.45 GF Score: 97/100

Q3 2020 Cadila Healthcare Ltd Earnings Call Transcript

Feb 05, 2020 / 12:30PM GMT
Release Date Price: ₹271.2 (+2.71%)
Operator

Ladies and gentlemen, good day, and welcome to the Q3 FY '20 Post Results Conference Call of Cadila Healthcare Limited. (Operator Instructions) Please note, this conference is being recorded.

I now hand the conference over to Mr. Ganesh Nayak COO, and Executive Director of Cadila Healthcare Limited. Thank you, and over to you, Mr. Nayak.

Ganesh Narayan Nayak
Cadila Healthcare Limited - COO & Executive Director

Welcome to the first earnings call of 2020, and I wish you all a very prosperous year ahead.

We have with us Dr. Sharvil Patel, Managing Director; Mr. Nitin Parekh, Chief Financial Officer; Mr. Harish Sadana, Chief Strategy Officer; and Vishal Gor, Senior Vice President, Corporate Finance.

During the third quarter of FY '20, we posted a consolidated revenue of INR 36.4 billion, up by 8%, adding INR 2.7 billion over INR 33.7 billion reported in the previous quarter. On the back of this increase, consolidated EBITDA grew to INR 6.93 billion, up 11% on a sequential basis, adding a delta of INR 676 million over the previous

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot